Princes Risborough man charged with intent to supply Class A drugs

Tuesday, 2 February 2021 12:36

A 19 year old man from Princes Risborough has been charged with possession with intent to supply heroin and crack cocaine.

He was arrested yesterday, alongside a 22 year old man from High Wycombe, after the vehicle they were travelling in was stopped by police.

Officers recovered a substantial amount of Class A drugs and cash.

They’ve both been been charged with possession with intent to supply heroin and crack cocaine.

The 22 year old has also been charged with use of a motor vehicle without insurance.

Both men have been remanded in custody and are due to appear in court today.

More from Local News

Serious incident in Aylesbury

Grafton Road has been closed by police for what has been described as a "serious incident".
Busy Aylesbury road to be closed for 2 weeks

The A418 through Bierton will be closed from Monday April 7th until Sunday April 20th.
Outcome of the Employment Tribunal Review

The Office of the Police and Crime Commissioner (OPCC) has today (3/4) published an independent review into Thames Valley Police's handling of the loss of a recent race discrimination Employment Tribunal and its diversity, inclusion and equalities policies more broadly.
Easter bin collection date changes

With Easter approaching, we're being reminded to take note of some changes to bin collections over the bank holiday weekend.
Lynx Aylesbury Celebrates GB Selections

Lynx Aylesbury Gymnastics Club is celebrating a momentous achievement as four of its talented gymnasts secure spots in the Great Britain squads for 2025/2026.
Heart of Bucks First Charity Tour

To celebrate their anniversary the community foundation is going ‘on-tour’ visiting a selection of the groups they have awarded grants to in that time.
TVP Closure Order in Wycombe

TVP Wycombe released this statement yesterday (2/4).
Locally based National Charity Invests in a Major Clinical Trial.

The ME Association, a national charity based in Gawcott, Bucks, has announced its investment in a major clinical trial in Canada to study the effects of low-dose naltrexone (LDN) on ME, chronic fatigue syndrome (CFS) and Long Covid.